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by the EPA and would be established in
statute under CEPA.) The EPA, along
with other government agencies, would
also conduct studies to identify the envi-
ronmental pollutants (and their unhealth-
ful constituents) commonly used or found
in areas that are "reasonably accessible to
children"-areas such as homes, schools,
day-care centers, malls, movie theaters,
and parks-and establish guidelines to
help reduce and eliminate exposure of
children to environmental pollutants in
such areas.
CEPA would expand the Toxics
Release Inventory to include releases of
certain substances that are believed to pose
special risks to children, such as lead and
mercury. The EPA would be charged with
identifying other toxic chemicals that may
be especially dangerous to children for
inclusion on the inventory.
Under CEPA, the EPA would publish
a list of"safer-for-children" substances and
products as well as a list ofenvironmental
chemicals that are known, likely, or sus-
pected to cause adverse health effects in
children. Both of these lists would be
available to the public and would name
household products in all different cate-
gories that present the minimum risk to
children. According to David Sandretti,
Boxer's communications director, the EPA
would be allowed considerable latitude in
composing the list in terms ofwhat items
to include and how to verify their safety,
whether through existing science or
through supplementary new studies. The
bill also calls for the creation of a family
information kit with information on how
to minimize children's exposures to toxic
substances.
The Children's Environmental Health
Network (CEHN), a nonpartisan research
and education consortium based in
Emeryville, California, has worked closely
with Boxer and Lautenberg in crafting the
bill. The CEHN has prepared an analysis
of the legislation that is available on their
Web site at http://www.cehn.org/. The
analysis notes a number of positive fea-
tures of the bill including its emphasis on
health in standard-setting and its endorse-
ment of much-needed research. Carol
Stroebel, health policy consultant for the
CEHN, says, "This bill will go a long way
toward instituting the kind of protections
that we need for children's health."
,KJN~ = Accessing Autoimmunity
As the body's police force, the human immune system has an astoundingly difficult
job. When viruses, bacteria, and other microbes break into the body each day, the
immune system must recognize and apprehend each of them. This involves produc-
ing specific molecules that will mark each invading microbe for destruction and then
calling the correct cells into action to annihilate it. Such a complicated task necessi-
tates a terrifically complex system, and that complexity also means there are many
things that can go wrong. When the immune system becomes confused and directs its
considerable force against the cells ofthe body instead of invaders, the result is often an
autoimmune disease.
Few autoimmune diseases can be cured. For the millions of Americans who have
developed lupus, type X diabetes, or any other of the 8o suspected autoimmune diseases,
that is the bad news. The good news is that there are groups like the American Autoimmune
Related Diseases Association (AARDA, pronounced "ARD ah") that are working to coordi-
nate an all-out attack on autoimmune illnesses while helping thosewho have such diseases
understand and live with them. The association disseminates the latest information on
these diseases through its site on the World Wide Web, located at http://www.aarda.org/.
For some peoplewith autoimmune disease, it is difficult to understand how such diverse
disorders as a leading cause of blindness in Asia(BehQet disease), a chronic gastrointestinal
disease (Crohn disease), a debilitating nerve disorder (multiple sclerosis), and a common
skin disease (psoriasis) can be related. Indeed, for many years, physicians approached each
ofthesediseases separately, notrealizing theyall maybecausedby autoimmunity.
To learn more about these diseases and
how the immune system causes them, visitors Au i
to the AARDA home page can follow the Q6A ReAmerdian Autoimmune
link, which contains general information about Related DiseasesAssociation, Inc.
autoimmunity, or the Disease Information link, __
which contains brief descriptions of 59 differ-
ent autoimmune diseases. Further information can be ordered from AARDA by clicking the
Request Information button at thebottom ofeach description. (Although the information is
free, a donation is requested.) The AARDA site also discusses why most of these diseases are
more likely to strike women than men. By some estimates, nearly 75% of all autoimmune
patients are female, and visitors to the AARDA site can read about some of thepossible rea-
sons forthis byfollowing the Autoimmunity and Women's Health link on the home page.
Recent advances in explaining this and other mysteries of autoimmune reactions can
be found in AARDA's newsletter or by following the links labeled Press Releases and
Research Reports on the AARDA home page. Though AARDA's full newsletter is available
only through paid subscription, some of the articles from past issues are provided on the
AARDA site and can be accessed by clicking the newspaper icon on the home page.
Included under the Press Releases link are articles about recent research breakthroughs,
such as the discovery of a gene that predisposes people to lupus, and other resources
including a free book about lupus that can be ordered from AARDA using a form linked to
the Press Releases page. Included under the Research Reports link are articles on topics
such as the use of stem cells to generate new liver tissue, the efficacy of new autoimmune
vaccines, and the etiology of diseases such as rheumatoid arthritis. Updates on research
grants and clinical trials arealso available here.
Besides providing this information to the public, AARDA also lobbies legislators to
make more grants and resources available for autoimmune research. In 1998, the group
helped persuade leaders to create a coordinating body for autoimmune research within the
National Institutes of Health. Information on these activities can be found by following the
Advocacy link on the home page. The group also sends updates by e-mail to those who
join its advocacy mailing list by filling in the form at the bottom of the Advocacy page.
Also here (and on the home page) is a link to AARDA's Congress Connect page, which lists
contact information, including e-mail links, for every member of Congress.
For people unfamiliar with the technical language in some of the articles on AARDA's
site, a list of terms is provided via the Glossary on the home page. Definitions for dozens of
words are listed on AARDA's Glossary page, and there is also a form for requesting informa-
tion about terms not listed.
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